AMASSE CAPITAL (08168) has announced a series of changes to its board of directors, effective February 6, 2026. Executive Directors Mr. Lu Minlin and Ms. Zeng Guangyun have resigned from their positions. Independent Non-Executive Directors Mr. Zhang Botao, Mr. Li Yongsen, and Dr. Yu Yuancheng have also resigned, citing a desire to dedicate more time to other personal commitments.

Concurrently, Mr. Xie Lei, Mr. Wu Peisheng, and Ms. Li Xianchang have been appointed as Executive Directors. Mr. Liu Zhanqing and Mr. Lin Haining have been appointed as Independent Non-Executive Directors.

Furthermore, effective February 6, 2026, Ms. Zeng Guangyun has stepped down as the company's authorized representative. The Company Secretary, Mr. Luo Xueru, has been appointed as the new authorized representative.

Additional committee changes taking effect from February 6, 2026, are as follows: (1) Ms. Zeng Guangyun has ceased to be a member of the Remuneration Committee and the Nomination Committee. (2) Mr. Zhang Botao has ceased to be the Chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee. (3) Mr. Li Yongsen has ceased to be the Chairman of the Audit Committee and a member of the Remuneration Committee. (4) Dr. Yu Yuancheng has ceased to be the Chairman of the Audit Committee and a member of the Nomination Committee. (5) Independent Non-Executive Director Ms. Huang Zhien has been appointed as the Chairman of the Audit Committee. (6) Mr. Liu Zhanqing has been appointed as the Chairman of both the Remuneration Committee and the Nomination Committee, and as a member of the Audit Committee. (7) Ms. Li Xianchang has been appointed as a member of the Remuneration Committee and the Nomination Committee. (8) Mr. Lin Haining has been appointed as a member of the Audit Committee, the Remuneration Committee, and the Nomination Committee.